A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer

Locally Advanced ◽

A Phase I/II Study of Neoadjuvant Liposomal Doxorubicin, Paclitaxel and Hyperthermia in Locally Advanced Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.751 ◽

2008 ◽

Vol 72 (1) ◽

pp. S183-S184

Author(s):

D.W. Kim ◽

K. Blackwell ◽

Z. Vujaskovic ◽

O. Craciunescu ◽

P. Stauffer ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial

Anti-Cancer Drugs ◽

10.1097/00001813-200501000-00003 ◽

2005 ◽

Vol 16 (1) ◽

pp. 21-29 ◽

Cited By ~ 11

Author(s):

Peter Schmid ◽

Jutta Krocker ◽

Carsten-Oliver Schulz ◽

Katarzyna Michniewicz ◽

Annette Dieing ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Advanced Breast ◽

Primary Chemotherapy

In regard to Kao et al.: Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive Phase I/II trials (Int J Radiat Oncol Biol Phys 2005;61:1045–1053)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.06.045 ◽

2005 ◽

Vol 63 (4) ◽

pp. 1276 ◽

Cited By ~ 2

Author(s):

Silvia C. Formenti

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase I ◽

Advanced Breast Cancer ◽

Radiat Oncol Biol Phys ◽

Locally Advanced ◽

Advanced Breast ◽

Consecutive Phase

Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

10.1200/jco.2004.22.14_suppl.3117 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3117-3117

Author(s):

F. J. Esteva ◽

T. L. Madden ◽

J. Lammey ◽

W. F. Symmans ◽

D. J. Booser ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

10.1200/jco.2004.22.90140.3117 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3117-3117

Author(s):

F. J. Esteva ◽

T. L. Madden ◽

J. Lammey ◽

W. F. Symmans ◽

D. J. Booser ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3008-5 ◽

2014 ◽

Vol 146 (1) ◽

pp. 145-152 ◽

Cited By ~ 25

Author(s):

Yifan Tu ◽

Dawn L. Hershman ◽

Kapil Bhalla ◽

Warren Fiskus ◽

Christine M. Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Deacetylase Inhibitor

Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3023-9 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1321-1321 ◽

Cited By ~ 2

Author(s):

Miriam König ◽

Cornelia von Hagens ◽

Sebastian Hoth ◽

Ingo Baumann ◽

Ingeborg Walter-Sack ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Phase I Study ◽

Locally Advanced ◽

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

The Breast ◽

10.1016/j.breast.2011.02.014 ◽

2011 ◽

Vol 20 (4) ◽

pp. 319-323 ◽

Cited By ~ 26

Author(s):

Silvia Dellapasqua ◽

Manuelita Mazza ◽

Debora Rosa ◽

Raffaella Ghisini ◽

Eloise Scarano ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Preoperative Treatment ◽

Metronomic Cyclophosphamide

Phase II study of neoadjuvant gemcitabine (GC), pegylated liposomal doxorubicin (DX) and docetaxel (TT) in locally advanced breast cancer

10.1200/jco.2008.26.15_suppl.606 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 606-606

Author(s):

G. Cartei ◽

L. Borgato ◽

G. Lombardi ◽

A. Cappetta ◽

F. Bozza ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Pegylated Liposomal Doxorubicin ◽

Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.

10.1200/jco.2014.32.15_suppl.598 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 598-598

Author(s):

Yifan Tu ◽

Dawn L. Hershman ◽

Christine M. Pellegrino ◽

Eleni Andreopoulou ◽

Della Makower ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel